Incremental Diagnostic Value of Serum Tumor Markers Beyond Multimodal Ultrasound for BI ‐ RADS Category 4 Breast Lesions
Journal of Ultrasound in Medicine · 16.11.2026
DOI: 10.1002/jum.70558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, online erschienen am 16.11.2026. Verfasst von Wei Xiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasonography, The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Medical Science Research Project of Hebei.
Abstract (Originalsprache)
Objectives
To determine the incremental diagnostic value and potential clinical utility of serum tumor markers beyond multimodal ultrasound for differentiating benign from malignant Breast Imaging Reporting and Data System category 4 breast lesions.
Methods
This retrospective diagnostic modeling study included 307 patients with 1 pathologically verified BI‐RADS category 4 lesion each. Three nested logistic regression models were evaluated: BI‐RADS subcategory alone, multimodal ultrasound comprising clinical and ultrasound variables, and multimodal ultrasound plus normalized serum CA15‐3, CEA, CA125, and CYFRA21‐1 ratios. Discrimination, calibration, Brier score, integrated discrimination improvement, likelihood‐ratio testing, bootstrap internal validation, and decision‐curve analysis were assessed. Prespecified analyses evaluated lesions 20 mm or smaller and patients with all 4 markers within reference limits.
Results
Of 307 lesions, 184 (59.9%) were malignant. The area under the receiver operating characteristic curve increased from 0.875 (95% CI, 0.837–0.913) for BI‐RADS alone to 0.920 (95% CI, 0.888–0.952) for multimodal ultrasound and 0.953 (95% CI, 0.931–0.976) after addition of serum markers. Relative to multimodal ultrasound, the combined model improved the AUC by 0.033 (95% CI, 0.013–0.055; p = .002), reduced the Brier score by 0.025 (95% CI, 0.011–0.040; p < .001), and yielded an integrated discrimination improvement of 0.103 (95% CI, 0.069–0.138; p < .001). Bootstrap‐corrected AUCs were 0.908 and 0.940, respectively. In lesions 20 mm or smaller, AUC increased from 0.934 to 0.970 ( p = .003). In the all‐marker‐negative subgroup, the corresponding increase from 0.912 to 0.930 was not statistically significant ( p = .229), although cohort‐derived combined‐model tertiles showed malignancy rates of 4.0, 24.5, and 89.8% ( p for trend
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasonography, The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.
- Newborn Department, The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.
- Department of Clinical Laboratory, The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.
- Department of Clinical Pharmacy, The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.
Förderung
- Medical Science Research Project of Hebei
Zitieren
APA
Xiang, W., Ge, H., Zhang, J., Cheng, Y., Chen, X., & Xue, J. (2026). Incremental Diagnostic Value of Serum Tumor Markers Beyond Multimodal Ultrasound for BI ‐ RADS Category 4 Breast Lesions. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.70558
Vancouver
Xiang W, Ge H, Zhang J, Cheng Y, Chen X, Xue J. Incremental Diagnostic Value of Serum Tumor Markers Beyond Multimodal Ultrasound for BI ‐ RADS Category 4 Breast Lesions. Journal of Ultrasound in Medicine. 2026. doi:10.1002/jum.70558
BibTeX
@article{Xiang2026,
author = {Xiang, Wei and Ge, Haiyan and Zhang, Jingrui and Cheng, Yiru and Chen, Xia and Xue, Jianli},
title = {Incremental Diagnostic Value of Serum Tumor Markers Beyond Multimodal Ultrasound for BI ‐ RADS Category 4 Breast Lesions},
journal = {Journal of Ultrasound in Medicine},
year = {2026},
doi = {10.1002/jum.70558}
}
EUVIMED